Skip to main content
. 2020 Jun 23;10:10186. doi: 10.1038/s41598-020-67147-7

Table 4.

Comparison of backgrounds in patients classified according to the presence of presaropenia and JIS score.

With presarcopenia and JIS score >3 (n = 17) With presarcopenia and JIS score <2 (n = 26) Without presarcopenia and JIS score >3 (n = 31) Without presarcopenia and JIS score <2 (n = 79)
Age: years, mean ± SD 68 ± 8.0 75 ± 8.6 71 ± 10 75 ± 8.6
Male: n (%) 15 (88) 25 (96) 25 (81) 49 (62)
BMI, mean ± SD 20 ± 3.2 22 ± 3.2 22 ± 3.6 23 ± 3.1
Complicated with diabetes: n (%) 6 (35) 6 (23) 8 (26) 24 (30)
Maximum size of HCC nodule in the liver: mm, median (range in IQR) 105(50–120) 29(20–52) 67(40–95) 25(15–41)
Number of HCC nodules: 1/2/3/4 or more, n 7/3/0/7 15/6/4/0 7/8/2/14 55/8/8/8
Presence of ascites: n (%) 9(53) 5(19) 12(39) 4(5)
Presence of hepatic encephalopathy: n (%) 1(6) 0(0) 4(13) 3(4)
Child-Pugh grade: A/B/C: n 2/10/5 22/2/2 10/15/6 59/19/1
HCC stage: 1/2/3/4: n 0/2/4/11 4/14/8/0 0/1/8/22 22/45/12/0
JIS score: 0/1/2/3/4/5: n 0/0/0/7/8/2 3/11/12/0/0/0 0/0/0/18/9/4 12/45/22/0/0/0
Albumin: g/dl, mean ± SD 2.9 ± 0.61 3.8 ± 0.64 3.3 ± 0.54 3.7 ± 0.52
Total bilirubin: g/dl, mean ± SD 2.8 ± 0.68 0.89 ± 0.37 2.4 ± 2.9 1.0 ± 0.57
γ-GTP: U/l, mean ± SD 285 ± 318 69 ± 70 257 ± 265 94 ± 108
Prothrombin time: %, mean ± SD 72 ± 22 86 ± 19 76 ± 19 86 ± 18
AFP: ng/ml, median (range in IQR) 284(17–28457) 39(6.1–127) 803(37–7781) 13(4.8–57)
AFP L3 index: %, median (range in IQR) 54(25–74) 6.8(0.5–28) 30(6.2–62) 4.6(0.5–12)
PIVKA-α: mAU/ml, median (range in IQR) 9618(6251–24752) 99(24–1702) 2018(125–17501) 45(20–314)
Taking BCAA: n (%) 6(35) 4(15) 11(36) 22(28)

Values are mean ± standard deviation. NASH; nonalcoholic steatohepatitis, BMI; body mass index, HCC; hepatocellular carcinoma, ALT; alanine aminotransferase, AFP; alpha-fetoprotein, AFP L3 fraction; Lens culinaris agglutinin-reactive fraction of AFP, PIVKA-II; prothrombin induced by vitamin K absence II.